• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

除 B 群之外的因子 H 结合蛋白分布:南非侵袭性脑膜炎奈瑟菌五个血清群之间的差异。

Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.

机构信息

National Institute for Communicable Diseases, Division of National Health Laboratory Service, Johannesburg, South Africa.

出版信息

Vaccine. 2011 Mar 3;29(11):2187-92. doi: 10.1016/j.vaccine.2010.11.072. Epub 2010 Dec 7.

DOI:10.1016/j.vaccine.2010.11.072
PMID:21144918
Abstract

Factor H binding protein (fHBP) is currently under investigation as a potential vaccine antigen for protection against meningococcal serogroup B (MenB) disease. This study describes the distribution of genotypes among all (n=58) MenB, and a total of 80 representative non-MenB (serogroups A, C, Y and W135) isolates causing invasive disease in South Africa in 2005 using fHBP sequence analysis, PorA, FetA and multilocus sequence typing. There was less fHBP diversity among non-MenB isolates compared to MenB isolates. fHBP subfamily variant A32 was the most common fHBP variant among MenB isolates and was represented by 17% (10/58) of the isolates, while fHBP variant B16 was the most prevalent variant among non-MenB strains and was represented by 40% (32/80) of isolates. Overall, subfamily B domain N6 (modular group I) was most prevalent (57%, 79/138). Twenty PorA and 16 FetA types were identified among MenB isolates whereas non-MenB serogroups were largely associated with specific serosubtypes. The most common MenB clonal complex (ST-41/44/lineage 3) was represented by 29% (17/58) of the MenB isolates, while each of the non-MenB serogroups had a major clone represented by at least 75% of the isolates within the serorogroup. Our data highlight that non-MenB meningococcal isolates also harbor fHBP.

摘要

因子 H 结合蛋白(fHBP)目前正在作为针对脑膜炎奈瑟菌 B 群(MenB)疾病的潜在疫苗抗原进行研究。本研究通过 fHBP 序列分析、PorA、FetA 和多位点序列分型,描述了南非 2005 年所有(n=58)MenB 以及总共 80 株引起侵袭性疾病的非 MenB(血清组 A、C、Y 和 W135)分离株的基因型分布。与 MenB 分离株相比,非 MenB 分离株的 fHBP 多样性较少。fHBP 亚家族变体 A32 是 MenB 分离株中最常见的 fHBP 变体,占分离株的 17%(10/58),而 fHBP 变体 B16 是非 MenB 菌株中最常见的变体,占分离株的 40%(32/80)。总体而言,亚家族 B 结构域 N6(模块组 I)最为常见(57%,79/138)。在 MenB 分离株中鉴定出 20 种 PorA 和 16 种 FetA 型,而非 MenB 血清组主要与特定的血清亚型相关。最常见的 MenB 克隆复合体(ST-41/44/谱系 3)占 MenB 分离株的 29%(17/58),而非 MenB 血清组中的每个血清组都有一个主要的克隆,占该血清组内分离株的至少 75%。我们的数据强调了非 MenB 脑膜炎奈瑟菌分离株也携带 fHBP。

相似文献

1
Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.除 B 群之外的因子 H 结合蛋白分布:南非侵袭性脑膜炎奈瑟菌五个血清群之间的差异。
Vaccine. 2011 Mar 3;29(11):2187-92. doi: 10.1016/j.vaccine.2010.11.072. Epub 2010 Dec 7.
2
Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.B群脑膜炎奈瑟菌流行病学相关菌株中补体H因子结合蛋白疫苗候选物的序列多样性
J Infect Dis. 2009 Aug 1;200(3):379-89. doi: 10.1086/600141.
3
Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.2015-2016 年美国三所大学学生携带的脑膜炎 B 型疫苗抗原的遗传多样性。
mBio. 2021 May 18;12(3):e00855-21. doi: 10.1128/mBio.00855-21.
4
Prevalence of factor H Binding Protein sub-variants among Neisseria meningitidis in China.中国脑膜炎奈瑟菌中H因子结合蛋白亚变体的流行情况。
Vaccine. 2017 Apr 25;35(18):2343-2350. doi: 10.1016/j.vaccine.2017.03.057. Epub 2017 Mar 25.
5
Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015-2018: Evolution of the vaccine antigen factor H binding protein (FHbp).2015-2018 年期间西班牙侵袭性 B 群脑膜炎奈瑟菌分离株的分子特征:疫苗抗原因子 H 结合蛋白(FHbp)的演变。
J Infect. 2021 Apr;82(4):37-44. doi: 10.1016/j.jinf.2021.01.030. Epub 2021 Feb 18.
6
Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010-2017).估计 B 群脑膜炎球菌疫苗的菌株覆盖率:希腊疾病和带菌菌株的回顾性研究(2010-2017 年)。
Vaccine. 2021 Mar 12;39(11):1621-1630. doi: 10.1016/j.vaccine.2021.01.073. Epub 2021 Feb 15.
7
Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.希腊B群脑膜炎球菌分离株的多样性及4CMenB脑膜炎球菌疫苗的估计覆盖率。
BMC Microbiol. 2014 Apr 29;14:111. doi: 10.1186/1471-2180-14-111.
8
Factor H binding protein (FHbp): An evaluation of genotypic diversity across serogroups.因子 H 结合蛋白(FHbp):对各血清群的基因多样性评估。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2409502. doi: 10.1080/21645515.2024.2409502. Epub 2024 Oct 10.
9
Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Strains and Their Predicted Coverage by the 4CMenB Vaccine.2010 至 2014 年加拿大确认文化的侵袭性脑膜炎奈瑟菌病:B 群菌株的特征及 4CMenB 疫苗的预测覆盖范围
mSphere. 2020 Mar 4;5(2):e00883-19. doi: 10.1128/mSphere.00883-19.
10
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Isolated from 2009 to 2013 in the Republic of Ireland.爱尔兰共和国 2009 至 2013 年分离的侵袭性 B 群血清型 4CMenB 疫苗的潜在覆盖范围。
mSphere. 2018 Aug 22;3(4):e00196-18. doi: 10.1128/mSphere.00196-18.

引用本文的文献

1
Factor H binding protein (FHbp): An evaluation of genotypic diversity across serogroups.因子 H 结合蛋白(FHbp):对各血清群的基因多样性评估。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2409502. doi: 10.1080/21645515.2024.2409502. Epub 2024 Oct 10.
2
Genomic Diversity and Antimicrobial Susceptibility of Invasive Neisseria meningitidis in South Africa, 2016-2021.2016 - 2021年南非侵袭性脑膜炎奈瑟菌的基因组多样性及抗菌药物敏感性
J Infect Dis. 2024 Dec 16;230(6):e1311-e1321. doi: 10.1093/infdis/jiae225.
3
Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.
对脑膜炎奈瑟菌 B 群侵袭性菌株的基因组监测:2016-2018 年巴西疫苗抗原类型的多样性。
PLoS One. 2020 Dec 21;15(12):e0243375. doi: 10.1371/journal.pone.0243375. eCollection 2020.
4
Broad vaccine protection against Neisseria meningitidis using factor H binding protein.利用补体因子 H 结合蛋白实现对脑膜炎奈瑟菌的广泛疫苗保护
Vaccine. 2020 Nov 17;38(49):7716-7727. doi: 10.1016/j.vaccine.2020.08.031. Epub 2020 Aug 30.
5
Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis.高毒力血清群W、ST-11型脑膜炎奈瑟菌的基因组流行病学
EBioMedicine. 2015 Sep 8;2(10):1447-55. doi: 10.1016/j.ebiom.2015.09.007. eCollection 2015 Oct.
6
Neisseria meningitidis porA, fetA and fHbp gene distribution in Western Australia 2000 to 2011.2000年至2011年西澳大利亚地区脑膜炎奈瑟菌porA、fetA和fHbp基因分布情况
BMC Infect Dis. 2014 Dec 12;14:686. doi: 10.1186/s12879-014-0686-x.
7
Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: implications for vaccine efficacy.居住在意大利米兰的青少年携带的 B 群脑膜炎奈瑟菌菌株的遗传特征:对疫苗效力的影响。
Hum Vaccin Immunother. 2013 Nov;9(11):2296-303. doi: 10.4161/hv.25800. Epub 2013 Jul 23.
8
Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.突变型天然外膜囊泡与A群多糖结合疫苗联合用于预防非洲脑膜炎球菌性流行病
PLoS One. 2013 Jun 21;8(6):e66536. doi: 10.1371/journal.pone.0066536. Print 2013.
9
Conservation of meningococcal antigens in the genus Neisseria.脑膜炎奈瑟菌属中脑膜炎球菌抗原的保守性。
mBio. 2013 Jun 11;4(3):e00163-13. doi: 10.1128/mBio.00163-13.
10
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.因子 H 结合蛋白在脑膜炎奈瑟菌毒力中的作用及其作为广泛预防脑膜炎球菌病疫苗候选物的潜力。
Microbiol Mol Biol Rev. 2013 Jun;77(2):234-52. doi: 10.1128/MMBR.00056-12.